Bio-Techne Corp
(STU:TE1)
€
69.5
0 (0%)
Market Cap: 11.07 Bil
Enterprise Value: 11.27 Bil
PE Ratio: 80.74
PB Ratio: 5.63
GF Score: 95/100 Bio-Techne Corp at Leerink Global Healthcare Conference Transcript
Feb 26, 2020 / 04:30PM GMT
Release Date Price:
€46
(+1.66%)
Puneet Souda
SVB Leerink LLC, Research Division - MD of Life Science Tools & Diagnostics and Senior Research Analyst
Jim, the first question that I have here -- and let's talk a little bit about the quarter.
Questions & Answers
Puneet Souda
SVB Leerink LLC, Research Division - MD of Life Science Tools & Diagnostics and Senior Research Analyst
You've traditionally grown about 10% to 12%. You maintained your guide there. Maybe just give us -- provide a bit of a backdrop of what happened in the quarter, onetime items. Are some of those things -- do you expect some of those to continue into the next couple of quarters here? And how should we think about the 10% to 12% for this year?
James T. Hippel
Bio-Techne Corporation - Senior VP of Finance & CFO
So yes, so Q2 was a lower quarter for us organic growth-wise and -- than what we've been accustomed to seeing. It was really -- a lot of it is driven out of Europe. Europe was -- it was down actually year-over-year for us, which has been double-digit
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot